Flowvium

기업 비교

공급망 포지션, 기관 신호, 뉴스 갭 스코어를 나란히 비교합니다.

VS

시가총액 구간

중형vs타이탄

체인 역할

intermediaryvsleader

갭 스코어

72vs5

IB 활동

80vs95

매출 구성 비교

MRNA
NVDA
MRN

Moderna, Inc.

MRNA · pharma-biotech

intermediary중형 ($1B+)
전체 프로필

소개

Moderna pioneered commercial mRNA technology with its COVID-19 vaccine and is now building a multi-product mRNA platform spanning infectious disease, oncology, and rare genetic disorders. Its RSV vaccine approval and cancer-vaccine pipeline represent the next phase of mRNA's therapeutic potential.

설립

2010

직원 수

6,000+

본사

Cambridge, Massachusetts, USA

매출

$8.8B

COVID-19 Vaccines62%
RSV Vaccine20%
Grants & Collaborations10%
Other Pipeline Products8%

뉴스 갭 신호

갭 스코어 (침묵 = 시그널)72
IB 활동 점수80
미디어 커버리지 점수30

IB 활동: HIGH

기관 신호

accumulating$83M

BlackRock

2024-08-13

reducing$28M

BlackRock

2024-08-13

accumulating$42M

BlackRock

2024-08-13

핵심 관계

PFE· Pfizer Inc.
competitor
LLY· Eli Lilly and Company
partner
REGN· Regeneron Pharmaceuticals
competitor
NVD

NVIDIA Corporation

NVDA · semiconductors

leader타이탄 ($1T+)
전체 프로필

소개

NVIDIA is the dominant designer of graphics processing units and AI accelerator chips. Its data-center GPU monopoly powers the generative-AI revolution, with the H100 and successor Blackwell GPUs serving as the de-facto standard for training and running large language models.

설립

1993

직원 수

32,000+

본사

Santa Clara, California, USA

매출

$130.5B

Data Center78%
Gaming12%
Professional Visualization4%
Automotive & Robotics4%
OEM & Other2%

뉴스 갭 신호

갭 스코어 (침묵 = 시그널)5
IB 활동 점수95
미디어 커버리지 점수98

IB 활동: HIGH

기관 신호

accumulating$6.2B

BlackRock

2024-08-13

accumulating$2.8B

BlackRock

2024-08-13

accumulating$3.0B

BlackRock

2024-08-13

핵심 관계

TSM· Taiwan Semiconductor Manufacturing Company
supplier
005930.KS· Samsung Electronics
supplier
000660.KS· SK Hynix
supplier
MU· Micron Technology
supplier
MSFT· Microsoft Corporation
customer